Spago Nanomedical completes fundraising round

By staff writers

July 1, 2022 -- Spago Nanomedical recently completed its rights issue fundraising round in a rights issue, saying it will raise about 58.4 million Swedish krona (5.4 million euros) before deduction of costs.

The company said the rights issue has been subscribed for about 94.6%, with 60.5% subscribed for with and without the exercise of subscription rights, and the other 34.1% subscribed for by guarantors.

Spago said funds raised will go toward beginning the clinical phase I/IIa-study for its lutetium-177-based radiopharmaceutical candidate 177Lu-SN201, planned to start in 2022.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking